A separate agency in the EOP from 1971 to 1975, SAODAP was responsible for providing leadership and coordination of all federal drug-abuse prevention activities (demand related) and to coordinate the demand-related activities with the supply-related efforts of law enforcement agencies.
Directors. Jerome H. Jaffe, 1971-1973 (also Consultant to the President for Narcotics and Dangerous Drugs) Robert L. Dupont 1973-1975.
Authorization and Role. Established by President Richard M. Nixon (E. O. 11599, June 17, 1971). Legislative authorization: Public Law 92-255, March 21, 1972; the ''Drug Abuse Office and Treatment Act of 1972.'' The director reported to the president, working through the Domestic Council and the White House staff. SAODAP had a staff of over 100 and an annual budget of approximately $50 million. About 50 percent of the budget was in a ''Special Fund for Drug Abuse'' to be transferred to other federal agencies as an incentive to develop more effective prevention programs.
SAODAP provided oversight of all categories of ''Demand Reduction ' functions and made recommendations to the Office of Management and Budget (OMB) on funding for drug-abuse programs. SAODAP published three federal strategies under the auspices of the relatively inactive Strategy Council on Drug Abuse.
When the authorizing statute expired on June 30, 1975, SAODAP's treatment, rehabilitation, and prevention functions were moved from the EOP to the National Institute on Drug Abuse in the Department of Health, Education, and Welfare.
Was this article helpful?